CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses.

MLA

Ma, Bing, et al. “CHI3L1 Regulates PD-L1 and Anti-CHI3L1-PD-1 Antibody Elicits Synergistic Antitumor Responses.” The Journal of Clinical Investigation, vol. 131, no. 21, Nov. 2021. EBSCOhost, https://doi.org/10.1172/JCI137750.

APA

Ma, B., Akosman, B., Kamle, S., Lee, C.-M., He, C. H., Koo, J. S., Lee, C. G., & Elias, J. A. (2021). CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses. The Journal of Clinical Investigation, 131(21). https://doi.org/10.1172/JCI137750

Chicago

Ma, Bing, Bedia Akosman, Suchitra Kamle, Chang-Min Lee, Chuan Hua He, Ja Seok Koo, Chun Geun Lee, and Jack A Elias. 2021. “CHI3L1 Regulates PD-L1 and Anti-CHI3L1-PD-1 Antibody Elicits Synergistic Antitumor Responses.” The Journal of Clinical Investigation 131 (21). doi:10.1172/JCI137750.